Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
Clinical trial NCT02256631 · COMPLETED
Trial details
- NCT number
- NCT02256631
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2020-06-17
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.